GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Key Capital Corp (GREY:KCPC) » Definitions » Valuation Rank

Key Capital (Key Capital) Valuation Rank


View and export this data going back to . Start your Free Trial

What is Key Capital Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Key Capital Valuation Rank Related Terms

Thank you for viewing the detailed overview of Key Capital's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Key Capital (Key Capital) Business Description

Traded in Other Exchanges
N/A
Address
4300 North Miller Road, Suite 230, Scottsdale, AZ, USA, 85251
Key Capital Corp is a United States based company engaged in the investment banking business with its prime focus on projects and opportunities within the Resources, Fintech, and Life Sciences market sectors. The company is focused on building a Mineral Bank of diverse commodities that will provide accretive streaming interests in diverse commodities in the Resources sector. In the Fintech sector, the company is focused on project development and involvement in the expanding blockchain/cryptocurrency market. In the Life Sciences sector, it focused on opportunities to bring breakthrough products to market.